Orgenesis Stock Price Prediction
| ORGS Stock | USD 0.15 0.05 25.00% |
Momentum 47
Impartial
Oversold | Overbought |
Using Orgenesis hype-based prediction, you can estimate the value of Orgenesis from the perspective of Orgenesis response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Orgenesis to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Orgenesis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Orgenesis after-hype prediction price | USD 0.15 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Orgenesis |
Orgenesis After-Hype Price Density Analysis
As far as predicting the price of Orgenesis at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Orgenesis or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Orgenesis, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Orgenesis Estimiated After-Hype Price Volatility
In the context of predicting Orgenesis' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Orgenesis' historical news coverage. Orgenesis' after-hype downside and upside margins for the prediction period are 0.01 and 57.65, respectively. We have considered Orgenesis' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Orgenesis is out of control at this time. Analysis and calculation of next after-hype price of Orgenesis is based on 3 months time horizon.
Orgenesis Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Orgenesis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Orgenesis backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Orgenesis, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
31.20 | 118.00 | 23.40 | 0.22 | 2 Events / Month | 1 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.15 | 0.15 | 0.00 |
|
Orgenesis Hype Timeline
Orgenesis is now traded for 0.15. The entity has historical hype elasticity of -23.4, and average elasticity to hype of competition of -0.22. Orgenesis is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 31.2%. %. The volatility of related hype on Orgenesis is about 1648044.69%, with the expected price after the next announcement by competition of -0.07. About 21.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.26. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Orgenesis recorded a loss per share of 8.0. The entity last dividend was issued on the 16th of November 2017. The firm had 1:10 split on the 25th of September 2024. Given the investment horizon of 90 days the next forecasted press release will be in a few days. Check out Orgenesis Basic Forecasting Models to cross-verify your projections.Orgenesis Related Hype Analysis
Having access to credible news sources related to Orgenesis' direct competition is more important than ever and may enhance your ability to predict Orgenesis' future price movements. Getting to know how Orgenesis' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Orgenesis may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SQZB | SQZ Biotechnologies | 0.00 | 0 per month | 0.00 | 0.02 | 3.45 | (3.33) | 50.43 | |
| HXBM | Helix BioMedix | 0.00 | 0 per month | 0.00 | (0.24) | 0.00 | (3.23) | 25.93 | |
| BPTH | Bio Path Holdings | (0.07) | 3 per month | 0.00 | (0.01) | 20.00 | (16.67) | 50.79 | |
| EMMA | Emmaus Life Sciences | 0.00 | 0 per month | 6.02 | 0.09 | 20.37 | (13.43) | 64.24 | |
| IDCN | Indocan Resources | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NTRR | Neutra Corp | (0.0002) | 4 per month | 21.55 | 0.13 | 100.00 | (50.00) | 150.00 | |
| PAIOF | Paion AG | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VPRO | Viropro | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| UNBX | Unity Biotechnology | 0.00 | 0 per month | 11.01 | 0 | 22.58 | (17.00) | 87.87 | |
| NGMC | Next Generation Management | (0) | 3 per month | 18.92 | 0.13 | 50.00 | (38.89) | 213.33 |
Orgenesis Additional Predictive Modules
Most predictive techniques to examine Orgenesis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Orgenesis using various technical indicators. When you analyze Orgenesis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Orgenesis Predictive Indicators
The successful prediction of Orgenesis stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Orgenesis, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Orgenesis based on analysis of Orgenesis hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Orgenesis's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Orgenesis's related companies.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Orgenesis Pink Sheet Analysis
When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.